Drug Profile
Research programme: small interfering RNA therapeutics - Kidswell Bio
Alternative Names: GND-007Latest Information Update: 28 Nov 2023
Price :
$50
*
At a glance
- Originator Gene Techno Science
- Developer Kidswell Bio
- Class Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 28 Nov 2023 No recent reports of development identified for research development in Immunological-disorders in Japan (Parenteral)
- 11 Nov 2021 Early research development is ongoing in Immunological disorders in Japan (Parenteral) (Kidswell Bio pipeline, November 2021)
- 01 Jul 2021 Gene Techno Science is now called Kidswell Bio